The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wiens, G. D.
Right arrow Articles by Rittenberg, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wiens, G. D.
Right arrow Articles by Rittenberg, M. B.

The Journal of Immunology, Vol 159, Issue 3 1293-1302, Copyright © 1997 by American Association of Immunologists


ARTICLES

Somatic mutation in VH complementarity-determining region 2 and framework region 2: differential effects on antigen binding and Ig secretion

GD Wiens, KA Heldwein, MP Stenzel-Poore and MB Rittenberg
Department of Molecular Microbiology and Immunology, Oregon Health Sciences University, Portland 97201, USA.

The extent to which somatic mutation impairs the Ig complementarity- determining region (CDR) and framework region (FRW) structure/function is not clear. Previously, we found that the VH CDR2 of the murine T15 Ab is highly sensitive to mutation; 56% (26 of 46) of Abs mutated in vitro had reduced or no Ag binding capability, and 9% were secretion impaired. Here we test whether the T15 VH CDR2 structure is unique by mutating the VH CDR2 of the anti-PC-protein murine Ab, PCG1-1. PCG1-1 VH is encoded by the M141 gene and is unrelated in sequence or structure to that of T15 VH1. The majority (54%, 20 of 37) of PCG1-1 mutants carrying one to five mutations in VH CDR2 had reduced or abolished Ag binding, while 10% were secretion impaired. Taken together, mutational analysis of the VH1 and VH M141 genes demonstrates that impaired binding and secretion may be common outcomes of CDR2 somatic mutation. We also tested the tolerance of the VH FRW2 of T15 to mutation, expecting this sequence-conserved region to be highly sensitive to alterations. However, FRW2 accommodated many nonconservative changes, and only 12% (3 of 25) of secreted mutants had impaired Ag binding. Moreover, mutations in FRW2 caused secretion defects in 24% (8 of 33), a frequency twice that of VH CDR2 mutants. A total of 16 unique secretion mutants have now been identified. These findings suggest that B cell losses from somatic mutation may be extensive and due to varied causes not all related to Ag binding.


This article has been cited by other articles:


Home page
J. Immunol.Home page
G. D. Wiens, M. Brown, and M. B. Rittenberg
Repertoire Shift in the Humoral Response to Phosphocholine-Keyhole Limpet Hemocyanin: VH Somatic Mutation in Germinal Center B Cells Impairs T15 Ig Function
J. Immunol., May 15, 2003; 170(10): 5095 - 5102.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. A. Whitcomb, T. M. Martin, and M. B. Rittenberg
Restoration of Ig Secretion: Mutation of Germline-Encoded Residues in T15L Chains Leads to Secretion of Free Light Chains and Assembled Antibody Complexes Bearing Secretion-Impaired Heavy Chains
J. Immunol., February 15, 2003; 170(4): 1903 - 1909.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
G. D. Wiens, R. Pascho, and J. R. Winton
A Single Ala139-to-Glu Substitution in the Renibacterium salmoninarum Virulence-Associated Protein p57 Results in Antigenic Variation and Is Associated with Enhanced p57 Binding to Chinook Salmon Leukocytes
Appl. Envir. Microbiol., August 1, 2002; 68(8): 3969 - 3977.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. S. Shapiro, K. Aviszus, J. Murphy, and L. J. Wysocki
Evolution of Ig DNA Sequence to Target Specific Base Positions Within Codons for Somatic Hypermutation
J. Immunol., March 1, 2002; 168(5): 2302 - 2306.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. D. Wiens, A. Lekkerkerker, I. Veltman, and M. B. Rittenberg
Mutation of a Single Conserved Residue in VH Complementarity-Determining Region 2 Results in a Severe Ig Secretion Defect
J. Immunol., August 15, 2001; 167(4): 2179 - 2186.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W. M. Aarts, R. J. Bende, J. G. Bossenbroek, S. T. Pals, and C. J. M. van Noesel
Variable heavy-chain gene analysis of follicular lymphomas: subclone selection rather than clonal evolution over time
Blood, July 1, 2001; 98(1): 238 - 240.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
M. Brown, M. A. Schumacher, G. D. Wiens, R. G. Brennan, and M. B. Rittenberg
The Structural Basis of Repertoire Shift in an Immune Response to Phosphocholine
J. Exp. Med., June 19, 2000; 191(12): 2101 - 2112.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. O'Hare, G. D. Wiens, E. A. Whitcomb, C. A. Enns, and M. B. Rittenberg
Cutting Edge: Proteasome Involvement in the Degradation of Unassembled Ig Light Chains
J. Immunol., July 1, 1999; 163(1): 11 - 14.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. England, R. Nageotte, M. Renard, A.-L. Page, and H. Bedouelle
Functional Characterization of the Somatic Hypermutation Process Leading to Antibody D1.3, a High Affinity Antibody Directed Against Lysozyme
J. Immunol., February 15, 1999; 162(4): 2129 - 2136.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. M. Martin, G. D. Wiens, and M. B. Rittenberg
Inefficient Assembly and Intracellular Accumulation of Antibodies with Mutations in VH CDR2
J. Immunol., June 15, 1998; 160(12): 5963 - 5970.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. D. Wiens, T. O'Hare, and M. B. Rittenberg
Recovering Antibody Secretion Using a Hapten Ligand as a Chemical Chaperone
J. Biol. Chem., October 26, 2001; 276(44): 40933 - 40939.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.